Biosimilar development and approval rely heavily on data obtained from structural characterization and comparability studies performed firstly on batches of the reference medicine and subsequently in head-to-head comparisons against batches of the biosimilar candidates. Biosimilar testing will assess the structural, physicochemical, biophysical and functional properties of the molecules.